Vestal Point Capital »

Rezolute shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.0M 1.7M 2.36

More positions owned by Vestal Point Capital

Abivax SA Sponsored Ads (ABVX)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
BioMarin Pharmaceutical (BMRN)
Globus Medical Cl A (GMED)
Nurix Therapeutics (NRIX)
Alcon Ord Shs (ALC)
Dex (DXCM)
Merck & Co (MRK)
Taysha Gene Therapies Com Shs (TSHA)
Abbott Laboratories (ABT)
Immatics NV SHS (IMTX)
Tyra Biosciences (TYRA)
Bicara Therapeutics (BCAX)

View all positions for Vestal Point Capital

Top funds holding Rezolute

Federated Investors
FMR
BlackRock
Opaleye Management
Vanguard Group
State Street Corporation
Blackstone Group
UBS Group
Affinity Asset Advisors
Integral Health Asset Management
Geode Capital Management
Barclays
Balyasny Asset Management
Vestal Point Capital
Jane Street

View all funds holding Rezolute